Filing Details
- Accession Number:
- 0001415889-23-006805
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-24 16:30:11
- Reporting Period:
- 2023-04-20
- Accepted Time:
- 2023-04-24 16:30:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910 | Chairperson & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-04-20 | 8,000 | $113.08 | 8,130 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-04-20 | 835 | $223.76 | 7,295 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-04-20 | 6,099 | $224.94 | 1,196 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-04-20 | 1,066 | $225.61 | 130 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2023-04-21 | 8,000 | $113.08 | 8,130 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-04-21 | 1,307 | $226.57 | 6,823 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-04-21 | 1,631 | $227.47 | 5,192 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-04-21 | 1,250 | $228.80 | 3,942 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-04-21 | 1,800 | $229.73 | 2,142 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-04-21 | 2,012 | $230.57 | 130 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | Disposition | 2023-04-20 | 8,000 | $0.00 | 8,000 | $113.08 |
Common Stock | Stock Options | Disposition | 2023-04-21 | 8,000 | $0.00 | 8,000 | $113.08 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
64,000 | 2013-12-31 | 2023-12-31 | No | 4 | M | Direct |
56,000 | 2013-12-31 | 2023-12-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 166 | Indirect | By Spouse |
Common Stock | 644,183 | Indirect | By Trusts |
Footnotes
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.
- This transaction was executed in multiple trades at prices ranging from $223.415 to $224.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $224.425 to $225.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $225.43 to $225.785. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $225.94 to $226.905. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $227.05 to $228.035. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $228.15 to $229.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $229.16 to $230.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $230.40 to $230.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.